7, 2025 — A research team has made a major discovery on how the CUL5 gene affects CAR-T cell therapy ... Life-Changing for Adults With Hemophilia B Sep. 25, 2024 — Adults with hemophilia ...

The following is a summary of “Identification of molecular clusters and a risk prognosis model for diffuse large B-cell lymphoma based on lactate metabolism-related genes,” published in the April 2025 ...

The phase I EXCELERIZE dose-escalation study will evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and preliminary efficacy of REC-3565 for treating R/R B-cell lymphomas in ...

SEATTLE, April 08, 2025 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune ...

Precomplexed AFM13-NK cells are more readily able to find and eliminate CD30-positive lymphoma cells. The technique was explored in “Emerging Frontiers in Immunotherapy: The Promise of NK-Cell ...

Public school educators invited to participate in 5-minute survey that will ultimately shape set of evidence-based recommendations for managing student cell phone use "A recent poll shows most ...

The breakdown of distributed products was as follows: axicabtagene ciloleucel (axi-cel; Yescarta) for diffuse large B-cell lymphoma (DLBCL) in the third line (27%), axi-cel for DLBCL in the second ...

When he was first diagnosed with mantle cell lymphoma in New York in 2005, Cannella said he was told he had three to five years to live, so he opted for a clinical trial. That worked, for a while.

COLUMBUS, Ohio — Thousands of dollars in federal grant money for LGBTQ+ historical markers across Ohio have been cut. The Ohio History Connection said the $250,000 in funds was meant to support ...

From the Department of Cardiology and Angiology I, University Heart Center Freiburg, Germany (D.W.) Faculty of Medicine, University of Freiburg, Germany (D.W.) K. Ley has received research funding for ...

These findings suggest this unique cell therapy approach has promise for specific patients with lymphoma, but it may be adapted for more cancer types in the future. "We observed rapid and strong ...